Exhibit 99.1
AMERISOURCEBERGEN CORPORATION
SUMMARY SEGMENT INFORMATION
(in thousands)
(unaudited)
The following illustrates revised reportable segment revenue information for the periods indicated:
|
| | | | | | | | | | | | | | | | | | | | |
| | | Fiscal Year Ended September 30, 2017 |
| Revenue | | First Quarter | | Second Quarter | | Third Quarter | | Fourth Quarter | | Fiscal Year |
| | | (As Revised) | | (As Revised) | | (As Revised) | | | | |
| Pharmaceutical Distribution Services | | $ | 36,798,288 |
| | $ | 35,745,361 |
| | $ | 37,255,195 |
| | $ | 37,654,651 |
| | $ | 147,453,495 |
|
| Other | | 1,384,490 |
| | 1,415,850 |
| | 1,467,536 |
| | 1,479,987 |
| | 5,747,863 |
|
| Intersegment eliminations | | (13,513 | ) | | (13,809 | ) | | (15,587 | ) | | (14,623 | ) | | (57,532 | ) |
| Revenue | | $ | 38,169,265 |
| | $ | 37,147,402 |
| | $ | 38,707,144 |
| | $ | 39,120,015 |
| | $ | 153,143,826 |
|
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | Fiscal Year Ended September 30, 2016 |
| Revenue | | First Quarter | | Second Quarter | | Third Quarter | | Fourth Quarter | | Fiscal Year |
| | | (As Revised) | | (As Revised) | | (As Revised) | | (As Revised) | | (As Revised) |
| Pharmaceutical Distribution Services | | $ | 35,440,095 |
| | $ | 34,420,594 |
| | $ | 35,583,985 |
| | $ | 36,257,323 |
| | $ | 141,701,997 |
|
| Other | | 1,280,620 |
| | 1,291,322 |
| | 1,315,545 |
| | 1,319,608 |
| | 5,207,095 |
|
| Intersegment eliminations | | (11,669 | ) | | (13,559 | ) | | (17,850 | ) | | (16,328 | ) | | (59,406 | ) |
| Revenue | | $ | 36,709,046 |
| | $ | 35,698,357 |
| | $ | 36,881,680 |
| | $ | 37,560,603 |
| | $ | 146,849,686 |
|
AMERISOURCEBERGEN CORPORATION
SUMMARY SEGMENT INFORMATION
(dollars in thousands)
(unaudited)
The following illustrates revised reportable segment operating income information for the periods indicated:
|
| | | | | | | | | | | | | | | | | | | | |
| | | Fiscal Year Ended September 30, 2017 |
| Operating income | | First Quarter | | Second Quarter | | Third Quarter | | Fourth Quarter | | Fiscal Year |
| | | (As Revised) | | (As Revised) | | (As Revised) | | | | |
| Pharmaceutical Distribution Services | | $ | 379,060 |
| | $ | 484,878 |
| | $ | 379,976 |
| | $ | 399,715 |
| | $ | 1,643,629 |
|
| Other | | 107,148 |
| | 103,593 |
| | 91,338 |
| | 71,718 |
| | 373,797 |
|
| Intersegment eliminations | | (13 | ) | | (1 | ) | | (198 | ) | | (344 | ) | | (556 | ) |
| Total segment operating income | | $ | 486,195 |
| | $ | 588,470 |
| | $ | 471,116 |
| | $ | 471,089 |
| | $ | 2,016,870 |
|
| | | | | | | | | | | |
| Percentages of revenue: | | | | | | | | | | |
| | | | | | | | | | | |
| Pharmaceutical Distribution Services | | | | | | | | | | |
| Gross profit | | 2.05% | | 2.42% | | 2.03% | | 2.14% | | 2.16% |
| Operating expenses | | 1.02% | | 1.07% | | 1.01% | | 1.07% | | 1.04% |
| Operating income | | 1.03% | | 1.36% | | 1.02% | | 1.06% | | 1.11% |
| | | | | | | | | | | |
| Other | | | | | | | | | | |
| Gross profit | | 22.36% | | 21.49% | | 20.26% | | 19.82% | | 20.96% |
| Operating expenses | | 14.63% | | 14.17% | | 14.03% | | 14.97% | | 14.45% |
| Operating income | | 7.74% | | 7.32% | | 6.22% | | 4.85% | | 6.50% |
|
| | | | | | | | | | | | | | | | | | | | |
| | | Fiscal Year Ended September 30, 2016 |
| Operating income | | First Quarter | | Second Quarter | | Third Quarter | | Fourth Quarter | | Fiscal Year |
| | | (As Revised) | | (As Revised) | | (As Revised) | | (As Revised) | | (As Revised) |
| Pharmaceutical Distribution Services | | $ | 385,629 |
| | $ | 502,967 |
| | $ | 416,096 |
| | $ | 398,033 |
| | $ | 1,702,725 |
|
| Other | | 91,190 |
| | 91,154 |
| | 79,146 |
| | 66,256 |
| | 327,746 |
|
| Intersegment eliminations | | — |
| | — |
| | — |
| | (103 | ) | | (103 | ) |
| Total segment operating income | | $ | 476,819 |
| | $ | 594,121 |
| | $ | 495,242 |
| | $ | 464,186 |
| | $ | 2,030,368 |
|
| | | | | | | | | | | |
| Percentages of revenue: | | | | | | | | | | |
| | | | | | | | | | | |
| Pharmaceutical Distribution Services | | | | | | | | | | |
| Gross profit | | 2.18% | | 2.56% | | 2.23% | | 2.16% | | 2.28% |
| Operating expenses | | 1.09% | | 1.10% | | 1.06% | | 1.06% | | 1.08% |
| Operating income | | 1.09% | | 1.46% | | 1.17% | | 1.10% | | 1.20% |
| | | | | | | | | | | |
| Other | | | | | | | | | | |
| Gross profit | | 21.89% | | 22.15% | | 20.80% | | 20.19% | | 21.25% |
| Operating expenses | | 14.77% | | 15.09% | | 14.78% | | 15.17% | | 14.95% |
| Operating income | | 7.12% | | 7.06% | | 6.02% | | 5.02% | | 6.29% |
